The NIH has announced their late application policy due to the evolving COVID-19 situation. In brief, the NIH will consider accepting late grant applications “on a case-by-case basis” and institutions must submit a cover letter of explanation.
Please be aware that we are actively engaging in discussions with the NIH at this time. We will share any additional guidance we receive.
Summary: The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research. Applications are welcome that propose any research topic relevant to the broad mission of NIH and from any eligible institution. NIH especially encourages applications from women and members of groups that are underrepresented in NIH-funded research.The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs.
The Transformative Research Award has separate funding opportunities available for COVID-19-related research to be supported by Emergency funds through the CARES Act. Applicants should apply to the appropriate funding opportunity based on their research topic. Applications submitted to the Emergency and non-Emergency funding opportunities will be reviewed together at the same time using the same process.
FY2021 NIH Director’s Transformative Research Award (R01 – Clinical Trial Optional): RFA RM-20-013
FY2021 NIH Director’s Emergency Transformative Research Award (R01 – Clinical Trial Optional): COVID-19 Proposals RFA RM-20-020
Summary: Supports the need to provide creative on-line instructional materials for both structural biologists having little or no prior experience with cryoEM or cryoET and biological scientists entirely new to structural biology. The expectation is that the curricula developed through this program will augment other hands-on skill enhancement activities, along with developing core competencies in cryoEM and cryoET research.